Kevin DeGeeter
Stock Analyst at Ladenburg Thalmann & Co.
(4.70)
# 739
Out of 4,361 analysts
427
Total ratings
38%
Success rate
19.2%
Average return
Main Sectors:
Stocks Rated by Kevin DeGeeter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLRB Cellectar Biosciences | Initiated Coverage: Buy | $5.5 → $10 | $2.74 | +264.96% | 13 | May 15, 2026 | |
| URGN UroGen Pharma | Initiated Coverage: Buy | $43 | $26.54 | +62.02% | 1 | May 11, 2026 | |
| TRAW Traws Pharma | Initiated Coverage: Buy | $6.5 | $1.42 | +357.75% | 1 | Jan 30, 2026 | |
| DCOY Decoy Therapeutics | Initiated Coverage: Buy | $2.5 | $8.61 | -70.96% | 1 | Jan 23, 2026 | |
| ORIC ORIC Pharmaceuticals | Maintained: Buy | $15 | $7.62 | +96.85% | 21 | Nov 14, 2025 | |
| CRDF Cardiff Oncology | Reiterated: Buy | $19 | $1.51 | +1,158.28% | 2 | Nov 10, 2025 | |
| NXTC NextCure | Upgraded: Buy | $18 | $3.40 | +429.41% | 1 | Nov 7, 2025 | |
| OPK OPKO Health | Maintained: Buy | $5.2 → $3 | $1.40 | +114.29% | 10 | Oct 30, 2025 | |
| NVCR NovoCure | Initiated Coverage: Buy | $98 → $30 | $15.82 | +89.63% | 13 | Jul 8, 2025 | |
| IONS Ionis Pharmaceuticals | Maintained: Buy | $63 → $59 | $72.97 | n/a | 18 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $4.07 | n/a | 1 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $37 | $5.69 | n/a | 9 | Apr 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $7 | $0.0001 | n/a | 13 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $17 | $2.04 | n/a | 2 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $24 | $11.14 | n/a | 21 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $141 → $125 | $18.70 | n/a | 20 | Jan 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $1.26 | n/a | 19 | Dec 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.5 → $5 | $0.00001 | n/a | 8 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.83 | n/a | 23 | Oct 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $0.3091 | n/a | 1 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $13.76 | n/a | 16 | Jul 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $2.46 | n/a | 18 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $3.75 | n/a | 6 | Jul 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $34.45 | n/a | 24 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $27.87 | n/a | 20 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $16.10 | n/a | 6 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5.5 | $0.000001 | n/a | 21 | Jun 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $4.00 | n/a | 1 | May 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $1.09 | n/a | 1 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.19 | n/a | 13 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.89 | n/a | 9 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.76 | n/a | 7 | Nov 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $10.21 | n/a | 22 | Jun 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.56 | n/a | 12 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 | $1.21 | n/a | 7 | May 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3 | $0.000001 | n/a | 1 | Jul 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $7.5 | $7.60 | n/a | 2 | Jun 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $14.52 | n/a | 2 | Apr 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.62 | n/a | 2 | Feb 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $4.31 | n/a | 6 | Feb 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $2.69 | n/a | 1 | Jan 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $33.08 | n/a | 5 | Dec 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 3 | Nov 13, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $45 | $1.15 | n/a | 1 | Oct 31, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $75 | $92.24 | n/a | 9 | Oct 30, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 | $0.5025 | n/a | 4 | Aug 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $121 | $328.26 | n/a | 2 | Apr 4, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $8.34 | n/a | 1 | Feb 28, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $86 | $127.57 | n/a | 2 | Jan 26, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.5 → $3 | $0.0001 | n/a | 2 | Nov 7, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $0.0008 | n/a | 1 | Oct 1, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.75 → $2.75 | $0.0001 | n/a | 2 | Aug 8, 2013 |
Cellectar Biosciences
May 15, 2026
Initiated Coverage: Buy
Price Target: $5.5 → $10
Current: $2.74
Upside: +264.96%
UroGen Pharma
May 11, 2026
Initiated Coverage: Buy
Price Target: $43
Current: $26.54
Upside: +62.02%
Traws Pharma
Jan 30, 2026
Initiated Coverage: Buy
Price Target: $6.5
Current: $1.42
Upside: +357.75%
Decoy Therapeutics
Jan 23, 2026
Initiated Coverage: Buy
Price Target: $2.5
Current: $8.61
Upside: -70.96%
ORIC Pharmaceuticals
Nov 14, 2025
Maintained: Buy
Price Target: $15
Current: $7.62
Upside: +96.85%
Cardiff Oncology
Nov 10, 2025
Reiterated: Buy
Price Target: $19
Current: $1.51
Upside: +1,158.28%
NextCure
Nov 7, 2025
Upgraded: Buy
Price Target: $18
Current: $3.40
Upside: +429.41%
OPKO Health
Oct 30, 2025
Maintained: Buy
Price Target: $5.2 → $3
Current: $1.40
Upside: +114.29%
NovoCure
Jul 8, 2025
Initiated Coverage: Buy
Price Target: $98 → $30
Current: $15.82
Upside: +89.63%
Ionis Pharmaceuticals
Apr 19, 2022
Maintained: Buy
Price Target: $63 → $59
Current: $72.97
Upside: n/a
Apr 19, 2022
Initiated Coverage: Buy
Price Target: $22
Current: $4.07
Upside: n/a
Apr 1, 2022
Maintained: Buy
Price Target: $45 → $37
Current: $5.69
Upside: n/a
Mar 30, 2022
Maintained: Buy
Price Target: $9 → $7
Current: $0.0001
Upside: n/a
Mar 30, 2022
Maintained: Buy
Price Target: $19 → $17
Current: $2.04
Upside: n/a
Feb 25, 2022
Maintained: Buy
Price Target: $30 → $24
Current: $11.14
Upside: n/a
Jan 25, 2022
Maintained: Buy
Price Target: $141 → $125
Current: $18.70
Upside: n/a
Dec 27, 2021
Maintained: Buy
Price Target: $14
Current: $1.26
Upside: n/a
Nov 16, 2021
Reiterated: Buy
Price Target: $5.5 → $5
Current: $0.00001
Upside: n/a
Oct 1, 2021
Downgraded: Hold
Price Target: n/a
Current: $2.83
Upside: n/a
Sep 20, 2021
Initiated Coverage: Buy
Price Target: $30
Current: $0.3091
Upside: n/a
Jul 20, 2021
Maintained: Buy
Price Target: $7
Current: $13.76
Upside: n/a
Jul 13, 2021
Maintained: Buy
Price Target: $18
Current: $2.46
Upside: n/a
Jul 8, 2021
Maintained: Buy
Price Target: $18
Current: $3.75
Upside: n/a
Jun 30, 2021
Reiterated: Hold
Price Target: n/a
Current: $34.45
Upside: n/a
Jun 28, 2021
Maintained: Buy
Price Target: $25
Current: $27.87
Upside: n/a
Jun 28, 2021
Downgraded: Hold
Price Target: n/a
Current: $16.10
Upside: n/a
Jun 16, 2021
Maintained: Buy
Price Target: $5.5
Current: $0.000001
Upside: n/a
May 26, 2021
Initiated Coverage: Buy
Price Target: $25
Current: $4.00
Upside: n/a
Apr 29, 2021
Initiated Coverage: Buy
Price Target: $17
Current: $1.09
Upside: n/a
Mar 4, 2021
Rated: Hold
Price Target: n/a
Current: $4.19
Upside: n/a
Mar 4, 2021
Rated: Hold
Price Target: n/a
Current: $2.89
Upside: n/a
Nov 25, 2020
Rated: Hold
Price Target: n/a
Current: $1.76
Upside: n/a
Jun 15, 2020
Rated: Hold
Price Target: n/a
Current: $10.21
Upside: n/a
Feb 24, 2020
Rated: Hold
Price Target: n/a
Current: $5.56
Upside: n/a
May 9, 2019
Rated: Buy
Price Target: $3
Current: $1.21
Upside: n/a
Jul 10, 2018
Initiated Coverage: Buy
Price Target: $3
Current: $0.000001
Upside: n/a
Jun 13, 2018
Reiterated: Buy
Price Target: $13 → $7.5
Current: $7.60
Upside: n/a
Apr 10, 2017
Maintained: Buy
Price Target: $13
Current: $14.52
Upside: n/a
Feb 14, 2017
Downgraded: Hold
Price Target: n/a
Current: $0.62
Upside: n/a
Feb 8, 2017
Upgraded: Hold
Price Target: n/a
Current: $4.31
Upside: n/a
Jan 4, 2017
Upgraded: Buy
Price Target: n/a
Current: $2.69
Upside: n/a
Dec 15, 2014
Rated: Hold
Price Target: n/a
Current: $33.08
Upside: n/a
Nov 13, 2014
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Oct 31, 2014
Rated: Sell
Price Target: $45
Current: $1.15
Upside: n/a
Oct 30, 2014
Rated: Buy
Price Target: $75
Current: $92.24
Upside: n/a
Aug 7, 2014
Rated: Buy
Price Target: $3
Current: $0.5025
Upside: n/a
Apr 4, 2014
Rated: Hold
Price Target: $121
Current: $328.26
Upside: n/a
Feb 28, 2014
Initiated Coverage: Hold
Price Target: n/a
Current: $8.34
Upside: n/a
Jan 26, 2014
Rated: Buy
Price Target: $86
Current: $127.57
Upside: n/a
Nov 7, 2013
Reiterated: Buy
Price Target: $7.5 → $3
Current: $0.0001
Upside: n/a
Oct 1, 2013
Upgraded: Buy
Price Target: n/a
Current: $0.0008
Upside: n/a
Aug 8, 2013
Reiterated: Buy
Price Target: $1.75 → $2.75
Current: $0.0001
Upside: n/a